Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes

BACKGROUND Evidence suggests that physiologic pacing (dual-chamber or atrial) may be superior to single-chamber (ventricular) pacing because it is associated with lower risks of atrial fibrillation, stroke, and death. These benefits have not been evaluated in a large, randomized, controlled trial. METHODS At 32 Canadian centers, patients without chronic atrial fibrillation who were scheduled for a first implantation of a pacemaker to treat symptomatic bradycardia were eligible for enrollment. We randomly assigned patients to receive either a ventricular pacemaker or a physiologic pacemaker and followed them for an average of three years. The primary outcome was stroke or death due to cardiovascular causes. Secondary outcomes were death from any cause, atrial fibrillation, and hospitalization for heart failure. RESULTS A total of 1474 patients were randomly assigned to receive a ventricular pacemaker and 1094 to receive a physiologic pacemaker. The annual rate of stroke or death due to cardiovascular causes was 5.5 percent with ventricular pacing, as compared with 4.9 percent with physiologic pacing (reduction in relative risk, 9.4 percent; 95 percent confidence interval, -10.5 to 25.7 percent [the negative value indicates an increase in risk]; P=0.33). The annual rate of atrial fibrillation was significantly lower among the patients in the physiologic-pacing group (5.3 percent) than among those in the ventricular-pacing group (6.6 percent), for a reduction in relative risk of 18.0 percent (95 percent confidence interval, 0.3 to 32.6 percent; P=0.05). The effect on the rate of atrial fibrillation was not apparent until two years after implantation. The observed annual rates of death from all causes and of hospitalization for heart failure were lower among the patients with a physiologic pacemaker than among those with a ventricular pacemaker, but not significantly so (annual rates of death, 6.6 percent with ventricular pacing and 6.3 percent with physiologic pacing; annual rates of hospitalization for heart failure, 3.5 percent and 3.1 percent, respectively). There were significantly more perioperative complications with physiologic pacing than with ventricular pacing (9.0 percent vs. 3.8 percent, P<0.001). CONCLUSIONS Physiologic pacing provides little benefit over ventricular pacing for the prevention of stroke or death due to cardiovascular causes.

[1]  Quality of Life and Clinical Outcomes in Elderly Patients Treated with Ventricular Pacing as Compared with Dual-Chamber Pacing , 1999 .

[2]  P. Grambsch,et al.  Proportional hazards tests and diagnostics based on weighted residuals , 1994 .

[3]  L. Rydén,et al.  A Double‐Blind Study of Submaximal Exercise Tolerance and Variation in Paced Rate in Atrial Synchronous Compared to Activity Sensor Modulated Ventricular Pacing , 1992, Pacing and clinical electrophysiology : PACE.

[4]  L. Thuesen,et al.  Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome , 1994, The Lancet.

[5]  M. Brignole,et al.  Intrapatient Comparison Between Chronic VVIR and DDD Pacing ‘In Patients Affected by High Degree AV Block Without Heart Failure , 1990, Pacing and clinical electrophysiology : PACE.

[6]  N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[7]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[8]  J Brandt,et al.  Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. , 1988, American heart journal.

[9]  A. Bernstein,et al.  Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual-chamber pacing. , 1992, Journal of the American College of Cardiology.

[10]  S. Connolly,et al.  Dual-chamber versus ventricular pacing. Critical appraisal of current data. , 1996, Circulation.

[11]  D.,et al.  Regression Models and Life-Tables , 2022 .

[12]  L. Rydén,et al.  Physiological Versus Single‐Rate Ventricular Pacing: A Double‐Blind Cross‐Over Study , 1985, Pacing and clinical electrophysiology : PACE.

[13]  L. Thuesen,et al.  Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome , 1997, The Lancet.